Hey Freud,
I've been providing outreach information about the anti-inflammatory regimen since December of 2010, a month after I developed it. Since then I've received valuable feedback from from hundreds of CHers taking it. Accordingly, this knowledge base provides answers to most questions. The online survey of CHers taking this regimen to prevent their CH has been running continuously since December of 2011. As of 1 Jan 2019, it's collected 293 completed and submitted surveys providing excellent clinical data.
With 80% of CHers who start this regimen experiencing a significant reduction in CH frequency from an average of 3 CH/Day down to 3 to 4 CH/week in the first 30 days and 50% of CHers starting this regimen experiencing a complete cessation of CH symptoms in the first 30 days, the anti-inflammatory regimen is the safest, most effective and least expensive CH prophylaxis available today. Moreover, thanks to the feedback and some dedicated research on other supplements, we are now able to address the 20% who don't respond to this regimen in the first 30 days. The most significant part of this regimen other than the vitamin D3 is diet. An Atkins-Ketogenic diet with zero sugars, zero wheat products and limited carbohydrates makes a huge difference. A Feb 2018 Italian study of 18 drug-resistant chronic CHers on this diet provided some eye popping results.
--------
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816269/
Introduction
Drug-resistant cluster headache (CH) is still an open clinical challenge. Recently, our group observed the clinical efficacy of a ketogenic diet (KD), usually adopted to treat drug-resistant epilepsies, or migraine.
Aim
Here, we aim to detect the effect of KD in a group of drug-resistant chronic CH (CCH) patients.
Materials and methods
Eighteen drug-resistant CCH patients underwent a 12-week KD (Modified Atkins Diet, MAD), and the clinical response was evaluated in terms of response (≥50% attack reduction).
Results
Of the 18 CCH patients, 15 were considered responders to the diet (11 experienced a full resolution of headache, and 4 had a headache reduction of at least 50% in terms of mean monthly number of attacks during the diet). The mean monthly number of attacks for each patient at the baseline was 108.71 (SD = 81.71); at the end of the third month of diet, it was reduced to 31.44 (SD = 84.61).
Conclusion
We observed for the first time that a 3-month ketogenesis ameliorates clinical features of CCH.
----------
I've been in contact by email with the Principal Investigator for this study and provided data on the efficacy of the anti-inflammatory regimen. We're both confident combining both therapies will result in a jump in efficacy to over 90%.
Sooo.... To my way of thinking, starting the anti-inflammatory regimen is a good move. Based on years of experience with this regimen, I'll wager your only regret will be you didn't start it sooner.
Take care and please keep us posted.
V/R, Batch